Nancy E. Katz - 24 May 2022 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)

Reporting relationship: Director
Issuer ticker: NURO
Reported as of: 24 May 2022
Net transaction value: +$60,000
SEC form: 4
Accepted by SEC: 26 May 2022, 15:27:58 UTC
Prior SEC filing: 20 Oct 2021
Next SEC filing: 05 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Thomas T. Higgins, Attorney-in-fact

Key filing fact

Nancy E. Katz filed Form 4 for NeuroMetrix, Inc. (NURO) on 26 May 2022.

Key facts

This page summarizes Nancy E. Katz's Form 4 filing for NeuroMetrix, Inc. (NURO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 May 2022, 15:27.

Change

Previous filing in this sequence was filed on 20 Oct 2021.
Current net transaction value: +$60,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NURO transaction Derivative

Restricted Stock Unit

Award

Transaction value: $60,000
Shares: +17,647
Change %
Price: $3.40
Shares after: 17,647
Date: 24 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,647
Exercise price: $3.40
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Nasdaq closing price on May 3, 2022, the date of Board of Directors approval.

Footnote F2

Grants were approved by the Company's Board of Directors on May 3, 2022 but were not issued until May 24, 2022 after the Company had filed a registration statement on Form S-8 to register the increase in capacity under its equity plans that was approved at the Company's Annual Shareholder Meeting held on May 3, 2022.

Footnote F3

100% vesting on May 2, 2023